Home LiteratureArticle Details
PMID: 27244487 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Intramural

International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.

International journal of cancer ·Vol. 139 ·No. 7 ·2016-00-01 ·Pages 1534-45

Petrick JL, Braunlin M, Laversanne M, Valery PC, Bray F, McGlynn KA

Abstract

Primary liver cancer, the most common histologic types of which are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is the second leading cause of cancer death worldwide. While rising incidence of liver cancer in low-risk areas and decreasing incidence in some high-risk areas has been reported, trends have not been thoroughly explored by country or by histologic type. We examined liver cancer incidence overall and by histology by calendar time and birth cohort for selected countries between 1978 and 2007. For each successive 5-year period, age-standardized incidence rates were calculated from volumes V-IX of the Cancer Incidence in Five Continents electronic database (CI5plus) and the newly released CI5X (volume X) database. Wide global variations persist in liver cancer incidence. Rates of liver cancer remain highest in Asian countries, specifically Eastern and South-Eastern Asian countries. While rates in most of these high-risk countries have been decreasing in recent years, rates in India and several low-risk countries of Africa, Europe, the Americas, and Oceania have been on the rise. Liver cancer rates by histologic type tend to convey a similar temporal profile. However, in Thailand, France, and Italy, ICC rates have increased while HCC rates have declined. We expect rates in high-risk countries to continue to decrease, as the population seroprevalence of hepatitis B virus (HBV) continues to decline. In low-risk countries, targeted screening and treatment of the hepatitis C virus (HCV), treatment of diabetes and primary prevention of obesity, will be key in reducing future liver cancer incidence.

Keywords
incidence international liver cancer trends
MeSH Terms
Adult Age Factors Aged Aged, 80 and over Carcinoma, Hepatocellular/epidemiology,pathology Cholangiocarcinoma/epidemiology,pathology Cohort Studies Female Global Health Humans Incidence Internationality Liver Neoplasms/epidemiology,pathology Male Middle Aged Sex Factors
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Petrick Jessica L
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Braunlin Megan
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Laversanne Mathieu
Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France.
Valery Patricia C
QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Bray Freddie
Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France.
McGlynn Katherine A
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
References (29)
29 references, click to expand
  1. Management of hepatocellular carcinoma: an update.
    Hepatology. 2011 Mar;53(3):1020-2 PMID: 21374666
  2. Graphical presentation of trends in rates.
    Am J Epidemiol. 1995 Feb 15;141(4):300-4 PMID: 7840107
  3. Sofosbuvir for previously untreated chronic hepatitis C infection.
    N Engl J Med. 2013 May 16;368(20):1878-87 PMID: 23607594
  4. Cancer risk diversity in non-western migrants to Europe: An overview of the literature.
    Eur J Cancer. 2010 Sep;46(14):2647-59 PMID: 20843493
  5. International testicular cancer incidence trends: generational transitions in 38 countries 1900-1990.
    Cancer Causes Control. 2015 Jan;26(1):151-8 PMID: 25388800
  6. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.
    Hepatology. 2004 Sep;40(3):652-9 PMID: 15349904
  7. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.
    Andrology. 2015 Jan;3(1):4-12 PMID: 25331326
  8. Global estimates of the prevalence of diabetes for 2010 and 2030.
    Diabetes Res Clin Pract. 2010 Jan;87(1):4-14 PMID: 19896746
  9. Screening and detection of hepatocellular carcinoma.
    Clin Liver Dis. 2015 May;19(2):295-307 PMID: 25921664
  10. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.
    Vaccine. 2012 Mar 9;30(12):2212-9 PMID: 22273662
  11. The epidemiology of obesity: the size of the problem.
    J Intern Med. 2008 Apr;263(4):336-52 PMID: 18312311
  12. The global epidemiology of hepatocellular carcinoma: present and future.
    Clin Liver Dis. 2011 May;15(2):223-43, vii-x PMID: 21689610
  13. HCV treatment--no more room for interferonologists?
    N Engl J Med. 2013 May 16;368(20):1931-2 PMID: 23607592
  14. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden.
    Gut. 2003 Apr;52(4):592-6 PMID: 12631675
  15. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China.
    Carcinogenesis. 2013 Aug;34(8):1800-5 PMID: 23322152
  16. Models for temporal variation in cancer rates. II: Age-period-cohort models.
    Stat Med. 1987 Jun;6(4):469-81 PMID: 3629048
  17. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003.
    Ann Intern Med. 2008 Jun 3;148(11):820-6 PMID: 18519928
  18. Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.
    Eur J Epidemiol. 2012 Jan;27(1):39-46 PMID: 22160277
  19. Permutation tests for joinpoint regression with applications to cancer rates.
    Stat Med. 2000 Feb 15;19(3):335-51 PMID: 10649300
  20. Geographical observation on cancer mortality by selected sites on the basis of standardised death rate.
    Gan. 1957 Jun;48(2):219-25 PMID: 13474150
  21. International trends in primary liver cancer incidence from 1973 to 2007.
    BMC Cancer. 2015 Mar 04;15:94 PMID: 25879744
  22. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology.
    J Gastroenterol Hepatol. 2002 Oct;17(10):1049-55 PMID: 12201863
  23. Models for temporal variation in cancer rates. I: Age-period and age-cohort models.
    Stat Med. 1987 Jun;6(4):449-67 PMID: 3629047
  24. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.
    Clin Liver Dis. 2015 May;19(2):223-38 PMID: 25921660
  25. International trends and patterns of primary liver cancer.
    Int J Cancer. 2001 Oct 15;94(2):290-6 PMID: 11668511
  26. Epidemiology of viral hepatitis and hepatocellular carcinoma.
    Gastroenterology. 2012 May;142(6):1264-1273.e1 PMID: 22537432
  27. Gender differences in cancer susceptibility: an inadequately addressed issue.
    Front Genet. 2012 Nov 28;3:268 PMID: 23226157
  28. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China.
    Cancer Prev Res (Phila). 2013 Oct;6(10):1038-45 PMID: 23963804
  29. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
    Am J Gastroenterol. 2013 Aug;108(8):1314-21 PMID: 23752878
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
1097-0215
Published
2016-00-01
Epub
2016-00-28
Pages
1534-45
Language
English
Region
United States
NLM ID
0042124
PMCID
PMC5310166
Subset
IM
Grants
Intramural NIH HHS · ZIA CP010158-16 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com